Sign inJoin waitlistJoin the waitlist

Seema Bhat

Physician · Ohio State University College of Medicine

Credentials: · · · · ·

History

Ohio State University College of Medicine
Present

Hematology and Medical Oncology
2002–2005
Internal Medicine
1999–2002
GOVT MED COLL, KASHMIR UNIV, SRINAGAR, JAMMU & KASHMIR, INDIA
1995–1999

Research

Hypertension and incident cardiovascular events following ibrutinib initiation
Blood · 2019 · 219 citations
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review
Review · JACC CardioOncology · 2023 · 114 citations
Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia
Journal of Clinical Oncology · 2020 · 90 citations

KR
Kerry Rogers
49 papers
Jennifer Woyach
45 papers
JB
John Byrd
35 papers
Adam Kittai
27 papers · 1 as a fellow
MG
Michael Grever
27 papers
Gerard Lozanski
13 papers
James Blachly
13 papers
Farrukh Awan
10 papers
David Bond
9 papers
Narendranath Epperla
9 papers
LA
Leslie Andritsos
8 papers
Sameer Parikh
8 papers

Clinical trials

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia
Principal investigator · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2026–2030
Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Principal investigator · Recruiting · Phase 2
Seema Bhat
2025–2027
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
Principal investigator · Recruiting · Phase 2
Seema Bhat
2023–2026
Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Principal investigator · Terminated · Phase 2
Roswell Park Cancer Institute
2012